INSIGHTS ON DRUG DEVELOPMENT

• Building A Human-Centric Future For Biologics Development

  Biologics are advancing rapidly, but complexity challenges traditional models. Gain insight into how human-relevant approaches like NAMs and microphysiological systems are gaining traction.

• Lipid Nanoparticles For Pulmonary Delivery Of mRNA

  Gain insight into how nebulized mRNA lipid nanoparticles show preclinical success in lung delivery, offering fresh momentum for inhaled gene therapies targeting respiratory diseases.

• An Integrated Analytical Approach To Lipase Risk Management In Biologics Development

  Conventional HCP testing cannot confirm whether residual lipases remain enzymatically active. Here, the authors examine why functional activity data are essential for managing polysorbate-related stability risk in biologics development.

• Spray Drying: The Key To Maximize Drug Solubility And Bioavailability

  Spray drying helps overcome formulation challenges by improving solubility, bioavailability, and particle performance for complex drug candidates.

• Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody

  3/24/2025

  Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.

• Mammalian Expression

  5/28/2026

  See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges. 

• Cell Culture Media Filtration: Evaluating Cell Culture Performance

  10/23/2025

  Cell culture performance remained consistent across PES and PVDF filters, even under worst-case filtration conditions. Discover a practical framework for evaluating membrane impact on CHO cell growth.

• Mechanical Engineering Design Process For Combination Products

  7/17/2026

  Mechanical engineering for combination drug-delivery devices demands more than good design — it requires data-driven risk management from specs through simulation. Learn how a structured phase approach ensures global manufacturing readiness.

• NGS In GMP Manufacturing: Reducing Risk, Increasing Return

  1/29/2026

  Global regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.